Next Article in Journal
The Role of Multi-Actor Engagement
Next Article in Special Issue
How Big Data Analytics Boosts Organizational Performance: The Mediating Role of the Sustainable Product Development
Previous Article in Journal
Civil Service, HR Potential, and Open Innovation
Previous Article in Special Issue
Social-Media Analysis for Disaster Prevention: Forest Fire in Artenara and Valleseco, Canary Islands
Article

A Field Study on the Impacts of Implementing Concepts and Elements of Industry 4.0 in the Biopharmaceutical Sector

Governance, Competitiveness and Public Policies, Competitiveness and Public Policies, Aveiro University, 3810-193 Aveiro, Portugal
*
Author to whom correspondence should be addressed.
J. Open Innov. Technol. Mark. Complex. 2020, 6(4), 175; https://doi.org/10.3390/joitmc6040175
Received: 3 September 2020 / Revised: 26 November 2020 / Accepted: 30 November 2020 / Published: 3 December 2020
(This article belongs to the Special Issue Big Data Research for Open Innovation)
This study proposes a field study, based on a literature review, about the applications and impacts of Industry 4.0 (I4.0) in the biopharmaceutical sector. The world is facing a new industrial revolution and the central idea is the integration between the virtual and the real world through elements that will allow for a greater degree of automation and digitization of processes. The production of medicines via biological processes is a booming domain in the pharmaceutical sector, that involves extraordinary technological challenges. The fieldwork, carried out between August 2019 and February 2020, involved semi-structured interviews with managers of pharmaceutical companies and specialists in the I4.0 theme. The interviews allowed for the identification of trends and key benefits and barriers for implementing I4.0 in the biopharmaceutical sector. While the perceptions were considerably diversified, benefits in productivity, competitiveness and quality ranked among the most scored items. The main barriers, highlighted by the interviewees, refer to the need to break organizational cultural standards, the regulatory requirements, the lack of organizational strategies for implementation, and the lack of qualified professionals. This work offers a contribution to the biopharmaceutical sector and reinforces the imminent need for companies to adapt to this new reality. View Full-Text
Keywords: Industry 4.0; Pharma 4.0; Biopharma 4.0; Bio 4.0 Industry 4.0; Pharma 4.0; Biopharma 4.0; Bio 4.0
Show Figures

Figure 1

MDPI and ACS Style

Silva, F.; Resende, D.; Amorim, M.; Borges, M. A Field Study on the Impacts of Implementing Concepts and Elements of Industry 4.0 in the Biopharmaceutical Sector. J. Open Innov. Technol. Mark. Complex. 2020, 6, 175. https://doi.org/10.3390/joitmc6040175

AMA Style

Silva F, Resende D, Amorim M, Borges M. A Field Study on the Impacts of Implementing Concepts and Elements of Industry 4.0 in the Biopharmaceutical Sector. Journal of Open Innovation: Technology, Market, and Complexity. 2020; 6(4):175. https://doi.org/10.3390/joitmc6040175

Chicago/Turabian Style

Silva, Felipe, David Resende, Marlene Amorim, and Monique Borges. 2020. "A Field Study on the Impacts of Implementing Concepts and Elements of Industry 4.0 in the Biopharmaceutical Sector" Journal of Open Innovation: Technology, Market, and Complexity 6, no. 4: 175. https://doi.org/10.3390/joitmc6040175

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop